caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1376956912

Melanie GammelPA-C

Physician AssistantSan Francisco, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Melanie Gammel's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Andrew Blecher
Family Practice · Van Nuys, CA
2449
Unilab Corporation
Clinical Laboratory · West Hills, CA
1353
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
HENRY MAYO NEWHALL MEMORIAL HOSPITAL3262
KARZEL, RONALD2354
Andrew Blecher
Family Practice · Van Nuys, CA
2251
Gregory Applegate
Diagnostic Radiology · Van Nuys, CA
1825
Unilab Corporation
Clinical Laboratory · West Hills, CA
1324
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
363
Unique beneficiaries
—
Total services
404
Distinct HCPCS
9
Medicare payment
$28K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,073 Physician Assistant providers in CA — above median (cohort median 224).
PRESCRIBING · PART D · 2024
Total Rx claims
156
Beneficiaries
—
Total drug cost
$4K
Distinct drugs
8
Brand share
61.5%
Top prescribed drugs
Azithromycin31 claims
Albuterol Sulfate28 claims
Amoxicillin/Potassium Clav24 claims
Cephalexin17 claims
Nirmatrelvir/Ritonavir16 claims
QUALITY · MIPS · 2024
Final MIPS score
99.6
Quality
86.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.04%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.